Incyte Stock Market Value
| INCY Stock | USD 51.65 0.27 0.52% |
| Symbol | Incyte |
Incyte Price To Book Ratio
Is Incyte's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Incyte. If investors know Incyte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Incyte listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 6.324 | Earnings Share 2.65 | Revenue Per Share 16.526 | Quarterly Revenue Growth 0.093 | Return On Assets 0.0646 |
The market value of Incyte is measured differently than its book value, which is the value of Incyte that is recorded on the company's balance sheet. Investors also form their own opinion of Incyte's value that differs from its market value or its book value, called intrinsic value, which is Incyte's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incyte's market value can be influenced by many factors that don't directly affect Incyte's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Incyte's value and its price as these two are different measures arrived at by different means. Investors typically determine if Incyte is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Incyte's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Incyte 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Incyte's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Incyte.
| 10/27/2023 |
| 04/24/2024 |
If you would invest 0.00 in Incyte on October 27, 2023 and sell it all today you would earn a total of 0.00 from holding Incyte or generate 0.0% return on investment in Incyte over 180 days. Incyte is related to or competes with Adaptimmune Therapeutics, Mereo BioPharma, PDS Biotechnology, Leap Therapeutics, X4 Pharmaceuticals, Corvus Pharmaceuticals, and Terns Pharmaceuticals. Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprie... More
Incyte Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Incyte's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Incyte upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.27) | |||
| Maximum Drawdown | 6.54 | |||
| Value At Risk | (2.40) | |||
| Potential Upside | 1.87 |
Incyte Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Incyte's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Incyte's standard deviation. In reality, there are many statistical measures that can use Incyte historical prices to predict the future Incyte's volatility.| Risk Adjusted Performance | (0.12) | |||
| Jensen Alpha | (0.29) | |||
| Total Risk Alpha | (0.44) | |||
| Treynor Ratio | (0.94) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Incyte's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Incyte Backtested Returns
Incyte holds Efficiency (Sharpe) Ratio of -0.19, which attests that the entity had a -0.19% return per unit of risk over the last 3 months. Incyte exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Incyte's Standard Deviation of 1.3, market risk adjusted performance of (0.93), and Risk Adjusted Performance of (0.12) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 0.28, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Incyte's returns are expected to increase less than the market. However, during the bear market, the loss of holding Incyte is expected to be smaller as well. Incyte has an expected return of -0.25%. Please make sure to check out Incyte treynor ratio, as well as the relationship between the accumulation distribution and price action indicator , to decide if Incyte performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.62 |
Very good reverse predictability
Incyte has very good reverse predictability. Overlapping area represents the amount of predictability between Incyte time series from 27th of October 2023 to 25th of January 2024 and 25th of January 2024 to 24th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Incyte price movement. The serial correlation of -0.62 indicates that roughly 62.0% of current Incyte price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.62 | |
| Spearman Rank Test | -0.59 | |
| Residual Average | 0.0 | |
| Price Variance | 5.63 |
Incyte lagged returns against current returns
Autocorrelation, which is Incyte stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Incyte's stock expected returns. We can calculate the autocorrelation of Incyte returns to help us make a trade decision. For example, suppose you find that Incyte has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Incyte regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Incyte stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Incyte stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Incyte stock over time.
Current vs Lagged Prices |
| Timeline |
Incyte Lagged Returns
When evaluating Incyte's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Incyte stock have on its future price. Incyte autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Incyte autocorrelation shows the relationship between Incyte stock current value and its past values and can show if there is a momentum factor associated with investing in Incyte.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Incyte Correlation, Incyte Volatility and Incyte Alpha and Beta module to complement your research on Incyte. For more information on how to buy Incyte Stock please use our How to Invest in Incyte guide.Note that the Incyte information on this page should be used as a complementary analysis to other Incyte's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Complementary Tools for Incyte Stock analysis
When running Incyte's price analysis, check to measure Incyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Incyte is operating at the current time. Most of Incyte's value examination focuses on studying past and present price action to predict the probability of Incyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Incyte's price. Additionally, you may evaluate how the addition of Incyte to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Incyte technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.